Literature DB >> 30527517

Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.

John C Mansour1, Kenneth Chavin2, Gareth Morris-Stiff3, Susanne G Warner4, Kenneth Cardona5, Zhi V Fong6, Ajay Maker7, Steven K Libutti8, Robert Warren9, Charles St Hill10, Scott Celinski11, Philippa Newell12, Quan P Ly13, James Howe14, Natalie Coburn15.   

Abstract

BACKGROUND: Variation in the management of PNETs exist due to the limited high-level evidence to guide clinical practice. The aim of this work is to generate consensus guidelines with a Delphi process for managing PNETs.
METHODS: A panel of experts reviewed the surgical literature and scored a set of clinical case statements using a web-based survey to identify areas of agreement and disagreement. Results of the survey were discussed after each round of review. This cycle was repeated until no further likelihood of reaching consensus existed.
RESULTS: Twenty-two case statements related to surgical indications, preoperative biopsy, extent of resection, type of surgery, and tumor location were scored. Using a pre-defined definition of consensus, the panel achieved consensus on the following: i) resection is not recommended for <1 cm lesions; ii) resection is recommended for lesions greater than 2 cm; iii) lymph node dissection is recommended for radiographically-suspicious nodes with splenectomy for distal lesions; iv) tumor enucleation and central pancreatectomy are acceptable when technically feasible. No consensus was reached regarding issues of preoperative biopsy or 1-2 cm tumors.
CONCLUSIONS: Using a structured, validated system for identifying consensus, an expert panel identified areas of agreement regarding critical management decisions for patients with PNET. Issues without consensus warrant additional clinical investigation.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30527517     DOI: 10.1016/j.hpb.2018.09.020

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  4 in total

1.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

2.  The Landmark Series: Pancreatic Neuroendocrine Tumors.

Authors:  Jordan M Cloyd; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2020-09-18       Impact factor: 5.344

3.  Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries.

Authors:  In Woong Han; Jangho Park; Eun Young Park; So Jeong Yoon; Gang Jin; Dae Wook Hwang; Kuirong Jiang; Wooil Kwon; Xuefeng Xu; Jin Seok Heo; De-Liang Fu; Woo Jung Lee; Xueli Bai; Yoo-Seok Yoon; Yin-Mo Yang; Keun Soo Ahn; Chunhui Yuan; Hyeon Kook Lee; Bei Sun; Eun Kyu Park; Seung Eun Lee; Sunghwa Kang; Wenhui Lou; Sang-Jae Park
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

4.  Immunotherapy improved cancer related pain management in patients with advanced Hepato-Pancreatic Biliary Cancers: A propensity score-matched (PSM) analysis.

Authors:  Xiufang Wu; Fei Qin; Qiangze Zhang; Jianling Qiao; Yulian Qi; Bing Liu
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.